Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Burke & Herbert Financial Services prices USD 100 million subordinated notes offering

Burke & Herbert Financial Services prices USD 100 million subordinated notes offering

BitgetBitget2026/09/28 19:37
  • Burke & Herbert Financial Services priced a USD 100 million public offering of 7.00% Fixed-to-Floating Rate Subordinated Notes due 2036.
  • Notes priced at 100% of principal; expected to close Sept. 30.
  • Coupon set at 7.00% through Oct. 1, 2031; then floats at three-month term SOFR + 222 basis points.
  • Proceeds earmarked for refinancing outstanding subordinated debt; remaining funds for general corporate purposes, including bank growth capital.
  • Issuer may redeem starting Oct. 1, 2031 at par; earlier redemption permitted upon specified events.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Burke & Herbert Financial Services Corp. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609281536PRIMZONEFULLFEED9835323) on September 28, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Uncertainty clouds the US stock IPO market as smart ring manufacturer Oura (OURA.US) joins the ranks of delayed listings

Oura (OURA.US) has become the latest company to postpone its initial public offering (IPO) in the United States due to market uncertainty.

智通财经•2026/09/29 11:36

AstraZeneca (AZN.US) invests in Summit (SMMT.US), gaining positive outlooks from JPMorgan and Citi: Cancer drug strategy awaits validation

Analysts from JPMorgan and Citi have welcomed the deal between AstraZeneca and Summit Therapeutics, stating that it aligns with AstraZeneca's cancer strategy.

智通财经•2026/09/29 11:06